Friend David相关文献与解析，生知库 | 链接生命科学的每一步

Guzeloglu-Kayisli Ozlem, Ozmen Asli, Un Busra Cetinkaya, Un Burak, Blas Jacqueline, Johnson Isabella, Thurman Andrea, Walters Mark, Friend David, Kayisli Umit A, Lockwood Charles J

FKBP5

发表日期：2025

文献求助收藏

Acceptability of and preferences for long-acting injectable hormonal contraception among US women: evidence from a national cross-sectional online survey

美国女性对长效注射型激素避孕的接受度和偏好：一项全国性横断面在线调查的证据

期刊:Contraception and Reproductive Medicine

影响因子:1.9

doi:10.1186/s40834-025-00380-5

Gottert, Ann; Abuya, Timothy; Proos, Elizabeth; Johnson, Isabella; Dormer, Nathan H; Foley, Ulrike; Saul, Grace; Haddad, Lisa B; Friend, David R

免疫/内分泌

发表日期：2025

文献求助收藏

Preliminary Efficacy of Topical Sildenafil Cream for the Treatment of Female Sexual Arousal Disorder: A Randomized Controlled Trial

局部应用西地那非乳膏治疗女性性唤起障碍的初步疗效：一项随机对照试验

期刊:Obstetrics and Gynecology

影响因子:4.7

doi:10.1097/AOG.0000000000005648

Johnson, Isabella; Thurman, Andrea Ries; Cornell, Katherine A; Hatheway, Jessica; Dart, Clint; Brainard, C Paige; Friend, David R; Goldstein, Andrew

发表日期：2024

文献求助收藏

Successful postcoital testing of Ovaprene: An investigational non-hormonal monthly vaginal contraceptive

Ovaprene 的性交后测试成功：一种在研的非激素性每月阴道避孕药

期刊:Contraception

影响因子:2.3

doi:10.1016/j.contraception.2024.110373

Mauck, Christine; Thurman, Andrea; Jensen, Jeffrey T; Schreiber, Courtney A; Baker, Jeff; Hou, Melody Y; Chavoustie, Steven; Dart, Clint; Wu, Hongsheng; Zack, Nadene; Hatheway, Jessica; Friend, David

免疫/内分泌

发表日期：2024

文献求助收藏

Impact of age, race, and medication use on efficacy endpoints in a randomized controlled trial of topical sildenafil cream for the treatment of female sexual arousal disorder

年龄、种族和药物使用对局部西地那非乳膏治疗女性性唤起障碍的随机对照试验疗效终点的影响

期刊:Sexual Medicine

影响因子:2

doi:10.1093/sexmed/qfae079

Johnson, Isabella; Thurman, Andrea Ries; Cornell, Katherine A; Dart, Clint; Hatheway, Jessica; Friend, David R; Goldstein, Andrew

发表日期：2024

文献求助收藏

Nanocurcumin combined with insulin alleviates diabetic kidney disease through P38/P53 signaling axis

纳米姜黄素联合胰岛素可通过P38/P53信号通路缓解糖尿病肾病。

期刊:Journal of Controlled Release

影响因子:10.5

doi:10.1016/j.jconrel.2022.12.012

Raghu Ganugula ,Nikhil K Nuthalapati ,Subhash Dwivedi ,Dianxiong Zou ,Meenakshi Arora ,Richard Friend ,David Sheikh-Hamad ,Rita Basu ,M N V Ravi Kumar

A phase 1/2, open-label, parallel group study to evaluate the safety and pharmacokinetics of DARE-HRT1 (80 μg estradiol/4 mg progesterone and 160 μg estradiol/8 mg progesterone intravaginal rings) over 12 weeks in healthy postmenopausal women

一项 1/2 期、开放标签、平行组研究，旨在评估 DARE-HRT1（80 μg 雌二醇/4 mg 孕酮和 160 μg 雌二醇/8 mg 孕酮阴道环）在健康绝经后妇女中 12 周的安全性和药代动力学。

期刊:Menopause-The Journal of the North American Menopause Society

影响因子:3

doi:10.1097/GME.0000000000002210

Thurman, Andrea; Hull, M Louise; Stuckey, Bronwyn; Hatheway, Jessica; Zack, Nadene; Mauck, Christine; Friend, David

发表日期：2023

文献求助收藏

A phase 1/2, open-label, parallel group study to evaluate the preliminary efficacy and usability DARE-HRT1 (80 μg estradiol/4 mg progesterone and 160 μg estradiol/8 mg progesterone intravaginal RinGSM) over 12 weeks in healthy postmenopausal women

一项 1/2 期、开放标签、平行组研究，旨在评估 DARE-HRT1（80 μg 雌二醇/4 mg 孕酮和 160 μg 雌二醇/8 mg 孕酮阴道内 RinGSM）在健康绝经后妇女中 12 周的初步疗效和可用性。

期刊:Menopause-The Journal of the North American Menopause Society

影响因子:3

doi:10.1097/GME.0000000000002230

Thurman, Andrea; Hull, M Louise; Stuckey, Bronwyn; Hatheway, Jessica; Zack, Nadene; Mauck, Christine; Friend, David

发表日期：2023

文献求助收藏

A Phase 1 pharmacokinetic study of a single-dose bioadhesive clindamycin 2% gel for bacterial vaginosis

一项针对细菌性阴道炎的单剂量2%生物粘附性克林霉素凝胶的I期药代动力学研究

期刊:Journal of Antimicrobial Chemotherapy

影响因子:3.6

doi:10.1093/jac/dkac386

Mauck, Christine K; Atiee, George J; McCulloh, Jennifer; Reynolds, Laurie; Zack, Nadene; Friend, David R

微生物学

发表日期：2022

文献求助收藏

Phase transition behaviour in yeast and bacterial populations under stress

酵母和细菌群体在压力下的相变行为

期刊:Royal Society Open Science

影响因子:2.9

doi:10.1098/rsos.192211

Ordway, Stephen W; King, Dawn M; Friend, David; Noto, Christine; Phu, Snowlee; Huelskamp, Holly; Inglis, R Fredrik; Olivas, Wendy; Bahar, Sonya

微生物学

发表日期：2020

文献求助收藏

Targeting FKBP51 prevents stress-induced preterm birth.

靶向FKBP51可预防应激诱发的早产

Acceptability of and preferences for long-acting injectable hormonal contraception among US women: evidence from a national cross-sectional online survey

美国女性对长效注射型激素避孕的接受度和偏好：一项全国性横断面在线调查的证据

Preliminary Efficacy of Topical Sildenafil Cream for the Treatment of Female Sexual Arousal Disorder: A Randomized Controlled Trial

局部应用西地那非乳膏治疗女性性唤起障碍的初步疗效：一项随机对照试验

Successful postcoital testing of Ovaprene: An investigational non-hormonal monthly vaginal contraceptive

Ovaprene 的性交后测试成功：一种在研的非激素性每月阴道避孕药

Impact of age, race, and medication use on efficacy endpoints in a randomized controlled trial of topical sildenafil cream for the treatment of female sexual arousal disorder

年龄、种族和药物使用对局部西地那非乳膏治疗女性性唤起障碍的随机对照试验疗效终点的影响

Nanocurcumin combined with insulin alleviates diabetic kidney disease through P38/P53 signaling axis

纳米姜黄素联合胰岛素可通过P38/P53信号通路缓解糖尿病肾病。

A phase 1/2, open-label, parallel group study to evaluate the safety and pharmacokinetics of DARE-HRT1 (80 μg estradiol/4 mg progesterone and 160 μg estradiol/8 mg progesterone intravaginal rings) over 12 weeks in healthy postmenopausal women

一项 1/2 期、开放标签、平行组研究，旨在评估 DARE-HRT1（80 μg 雌二醇/4 mg 孕酮和 160 μg 雌二醇/8 mg 孕酮阴道环）在健康绝经后妇女中 12 周的安全性和药代动力学。

A phase 1/2, open-label, parallel group study to evaluate the preliminary efficacy and usability DARE-HRT1 (80 μg estradiol/4 mg progesterone and 160 μg estradiol/8 mg progesterone intravaginal RinGSM) over 12 weeks in healthy postmenopausal women

一项 1/2 期、开放标签、平行组研究，旨在评估 DARE-HRT1（80 μg 雌二醇/4 mg 孕酮和 160 μg 雌二醇/8 mg 孕酮阴道内 RinGSM）在健康绝经后妇女中 12 周的初步疗效和可用性。

A Phase 1 pharmacokinetic study of a single-dose bioadhesive clindamycin 2% gel for bacterial vaginosis

一项针对细菌性阴道炎的单剂量2%生物粘附性克林霉素凝胶的I期药代动力学研究

Phase transition behaviour in yeast and bacterial populations under stress

酵母和细菌群体在压力下的相变行为